技術指標
指標
數值
方向
MACD(12,26,9)
-0.101
賣出
RSI(14)
42.565
中性
STOCH(KDJ)(9,3,3)
15.933
超賣
ATR(14)
0.534
低波動
CCI(14)
-90.847
中性
Williams %R
87.912
超賣
TRIX(12,20)
-0.197
賣出
StochRSI(14)
19.894
超賣
搜尋
Burning Rock Biotech Ltd
BNR添加自選
8.900USD
-0.050-0.56%
收盤 07-31 16:00（美東）報價延遲15分鐘
80.36M總市值
虧損本益比TTM
關鍵數據
9.060今開
9.060最高
1.47K成交量
虧損本益比TTM
--本益比動
--股利TTM
0.02%換手率
8.850昨收
8.875最低
10.15K成交額
虧損本益比靜
1.05市淨率
0.00%股息率 TTM
-6.49%ROA
41.72052週最高
0.96量比
-346.63M淨利潤
9.03M總股本
-0.7445每股盈餘TTM
1.38Beta
-9.92%ROE
2.80052週最低
2.09%振幅
72.27%毛利率
80.36M總市值
-1.89回報/風險
7.58%風險率
TradingKey Burning Rock Biotech Ltd股票評分
單位: USD 更新時間: 2026-07-31操作建議
Burning Rock Biotech Ltd當前公司基本面數據相對非常健康，增長潛力很大。當前估值合理，在醫療服務供應商行業排名58/75位。機構持股佔比非常高，中期看，股價處於下降通道。近一個月，市場表現較差，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Burning Rock Biotech Ltd評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
中性
Burning Rock Biotech Ltd亮點
亮點風險
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
業績增長期
公司處於發展階段，最新年度總收入78.24M美元
估值低估
公司最新PE估值-11.95，處於3年歷史低位
機構減倉
最新機構持股4.03M股，環比減少6.43%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉，最新持倉0.00股
分析師目標
基於
0
分析師
--
評級
--
目標均價
--
漲幅空間
Burning Rock Biotech Ltd新聞
即將為您帶來更多新聞，敬請期待。 。 。
技術指標
移動平均線
指標
數值
方向
MA5
9.032
賣出
MA10
9.199
賣出
MA20
9.865
賣出
MA50
9.712
賣出
MA100
13.971
賣出
MA200
17.727
賣出
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Burning Rock Biotech Ltd簡介
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
公司代碼BNR
公司Burning Rock Biotech Ltd
CEOHan (Yusheng)
網址https://www.brbiotech.com/
公司股東
相關品種
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
+0.10%
-6.42%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%
-0.78%熱門品種
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
常見問題
Burning Rock Biotech Ltd(BNR)的當前股價是多少？
Burning Rock Biotech Ltd(BNR)的當前股價是 8.90。
Burning Rock Biotech Ltd 的股票代碼是什麼？
Burning Rock Biotech Ltd的股票代碼是BNR。
Burning Rock Biotech Ltd股票的52週最高點是多少？
Burning Rock Biotech Ltd股票的52週最高點是41.72。
Burning Rock Biotech Ltd股票的52週最低點是多少？
Burning Rock Biotech Ltd股票的52週最低點是2.80。
Burning Rock Biotech Ltd的市值是多少？
Burning Rock Biotech Ltd的市值是80.36M。
Burning Rock Biotech Ltd(BNR)股票的每股收益（EPS TTM）是多少
Burning Rock Biotech Ltd(BNR)股票的每股收益（EPS TTM）是-0.74。